Abpro Holdings, Inc. (ABPO)
0.2293
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Abpro Holdings Total Liabilities (Quarterly) : 8.225M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.225M |
| March 31, 2026 | 9.117M |
| December 31, 2025 | 9.345M |
| September 30, 2025 | 17.30M |
| June 30, 2025 | 20.43M |
| March 31, 2025 | 20.61M |
| December 31, 2024 | 19.61M |
| September 30, 2024 | 19.54M |
| June 30, 2024 | 17.81M |
| March 31, 2024 | 17.10M |
| Date | Value |
|---|---|
| December 31, 2023 | 16.19M |
| September 30, 2023 | 16.01M |
| June 30, 2023 | 16.89M |
| March 31, 2023 | 13.66M |
| December 31, 2022 | 12.64M |
| September 30, 2022 | 11.76M |
| June 30, 2022 | 11.17M |
| March 31, 2022 | 10.89M |
| December 31, 2021 | 0.3382M |
| October 31, 2021 | 0.1516M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.241M |
| Shareholders Equity (Quarterly) | -3.533M |
| Debt to Equity Ratio | -0.0484 |
| Current Ratio | 0.6175 |
| Net Debt Paydown Yield | 52.38% |